We knew cr Was inevitable. Also even some of the research reports out intimated at the potential cost to get to phase 3 or market with current drugs. I vaguely recall they mentioned needing 44 mil over next few years. Hopefully this is just a quick fill in at low price and larger raise is done at much higher price when some efficacy results come I. Let's face it if they can announce that they have treated uti infection in human trial repeatedly and safely then that must do something. Currently they have proven they can iv inject reasonable doses with no adverse effect so that is good but actually treating any real world infection successfully by iv should be big news. Currently all sas updates are topical application I think?
RCE Price at posting:
54.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)